Apple Watch Series 12 Hypertension Alerts Delayed in 33 Countries
New Apple Watch Series 12 and Ultra 4 models may temporarily lack hypertension notifications in 33 countries due to ongoing regulatory clearances, impacting users who rely on the feature.
Owners of the upcoming Apple Watch Series 12 and Apple Watch Ultra 4 may experience a temporary loss of a key health feature: hypertension notifications. Apple has indicated on its feature availability page that these alerts might not be present at launch for the new models in 33 countries and regions as the company seeks additional regulatory clearances. This situation affects users who currently benefit from these notifications on older Apple Watch models.
The impacted regions include Canada, Australia, India, Brazil, Singapore, Japan, Taiwan, South Africa, South Korea, and the United Arab Emirates, among others. A comprehensive list is available on Apple's official website. Notably, the United States, the United Kingdom, and all European Union countries are not included in this list and will continue to receive notifications as usual. Users in these unaffected regions upgrading to the latest models can expect the feature to remain available.
New Health Sensing System Undergoes Regulatory Review
The temporary unavailability stems from the significant upgrades to the health sensors integrated into the Apple Watch Series 12 and Ultra 4. These new models boast a revamped Health Sensing System, featuring enhanced optical and electrical heart sensors. Apple reports these changes are designed for more frequent and accurate tracking of vital signs. The redesigned ECG functionality includes electrodes that cover a larger surface area for improved skin contact during readings. Furthermore, the optical sensing has been improved with redesigned photodiodes organized in a ring to capture light more efficiently.
The green LEDs in the optical heart rate sensor are now larger and more power-efficient, enabling the watches to measure heart rate every five seconds throughout the day. This continuous monitoring provides a wealth of data on a user's fitness and overall physiological state. Real-time heart rate data is accessible through the updated Heart Rate app, and the accuracy of Exercise and Move Activity rings has also been enhanced. Heart Rate Variability (HRV), an important metric for recovery and stress, is now measured as frequently as every five minutes.
This comprehensive overhaul of the heart monitoring capabilities, while offering significant potential benefits for users tracking their cardiovascular health, necessitates new regulatory approvals in various markets. The hypertension notification feature, which relies on these advanced sensors, must be specifically cleared by health authorities in each region before it can be re-enabled on the new devices. Users who have come to depend on these alerts for managing their blood pressure should remain vigilant for official announcements from Apple regarding the rollout of regulatory approvals in their specific locations.
The Apple Watch has increasingly positioned itself as a vital tool for personal health monitoring, extending beyond basic fitness tracking. Features like ECG readings, fall detection, and now hypertension risk assessment highlight the company's commitment to integrating sophisticated health technology into its wearable devices. The current situation, while inconvenient for some users, underscores the complex intersection of rapid technological innovation and the stringent requirements of global health regulations. Apple's proactive disclosure aims to manage user expectations as it navigates these processes.